BioSapien Inc.

Private
New York City, New YorkHealthcare & Life Scienceshttps.biosapien.com

Last Round

Series A

Extension

Jul 7, 2025

Total Funding Raised

$15.81M

Company Overview

BioSapien Inc. is a biotechnology company that has developed MediChip, a patented 3D-printed, biodegradable mesh chip designed to deliver pharmaceuticals directly to a tumor site.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, 3D Printing, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

drug delivery implantlocalized cancer treatmentlocal drug delivery3D-printed implantbiodegradable implantlocal chemotherapysolid tumor treatmentmedical 3D printingdrug-eluting implantpatient-specific implantpreclinical biotechdrug delivery systemcolorectal cancer treatmentimplantable device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioSapien Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BioSapien Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJul 7, 2025
Early FundingJan 27, 2025
Early FundingDec 12, 2024
SeedNov 11, 2021
GrantMay 1, 2021
Pre Seed
Oct 10, 2019

Key People

Founding team and executive leadership

Joseph Borrello

Chief Technology Officer

Executive Team

BioSapien Inc. Investors

Notable investors and investment history

InvestorRounds
Golden Gate VenturesEarly Funding, Series A Extension
Global VenturesEarly Funding, Series A Extension
Dara HoldingsEarly Funding, Series A Extension
Side Door VenturesSeed
Dara ManagementEarly Funding
GlobivestSeries A Extension
IndieBioPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2025

    Developing 3D-printed mesh for targeted chemotherapy delivery.

  • Jan 27, 2025

    Raised $7M in early funding.

BioSapien Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioSapien Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioSapien Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range12
Year Founded2018
Last FundingJul 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.